Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Astex Pharmaceuticals presents phase I results for AT-13387 in GIST

Jan. 25, 2013

Vismodegib + FOLFOX evaluated in gastroesophageal carcinoma

Jan. 25, 2013

New antitumor agents disclosed at Novartis

Jan. 24, 2013

FDA approves use of Avastin as part of second-line therapy for metastatic colorectal cancer

Jan. 24, 2013

New MAbs targeting AXL presented by French scientists

Jan. 24, 2013

EntreMed begins phase II study of ENMD-2076

Jan. 24, 2013

Celsion and Zhejiang Hisun Pharmaceutical enter into agreement for ThermoDox

Jan. 23, 2013

Replikins reports latest research

Jan. 23, 2013

Synthon reports early results from its HER2 antibody-drug conjugate

Jan. 23, 2013

Global phase I study of AZD-1208 commences

Jan. 22, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...